Qi et al. also have demonstrated that the AT1R/Raf/ERK1/2 pathway plays a key role in human HCC cell proliferation and identified Bcl-2 and c-Myc as downstream targets of this pathway [20]. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.